DK1082116T3 - Anvendelse af 4-piperidinmethanolderivater til behandling af neurologiske sygdomme - Google Patents

Anvendelse af 4-piperidinmethanolderivater til behandling af neurologiske sygdomme

Info

Publication number
DK1082116T3
DK1082116T3 DK99948543T DK99948543T DK1082116T3 DK 1082116 T3 DK1082116 T3 DK 1082116T3 DK 99948543 T DK99948543 T DK 99948543T DK 99948543 T DK99948543 T DK 99948543T DK 1082116 T3 DK1082116 T3 DK 1082116T3
Authority
DK
Denmark
Prior art keywords
treatment
neurological disorders
methanol derivatives
piperidine methanol
compound
Prior art date
Application number
DK99948543T
Other languages
Danish (da)
English (en)
Inventor
Maria Carlsson
Original Assignee
Carlsson A Research Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carlsson A Research Ab filed Critical Carlsson A Research Ab
Application granted granted Critical
Publication of DK1082116T3 publication Critical patent/DK1082116T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK99948543T 1998-04-30 1999-04-26 Anvendelse af 4-piperidinmethanolderivater til behandling af neurologiske sygdomme DK1082116T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9801516A SE9801516D0 (sv) 1998-04-30 1998-04-30 M100907/4-Piperidinemethanol derivatives for autism
PCT/SE1999/000683 WO1999056750A1 (fr) 1998-04-30 1999-04-26 Utilisation de derives de 4-piperidinemethanol dans le traitement de troubles neurologiques du developpement

Publications (1)

Publication Number Publication Date
DK1082116T3 true DK1082116T3 (da) 2003-07-21

Family

ID=20411144

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99948543T DK1082116T3 (da) 1998-04-30 1999-04-26 Anvendelse af 4-piperidinmethanolderivater til behandling af neurologiske sygdomme

Country Status (13)

Country Link
US (1) US6358977B1 (fr)
EP (1) EP1082116B1 (fr)
JP (1) JP2002513759A (fr)
AT (1) ATE236634T1 (fr)
AU (1) AU4301699A (fr)
CA (1) CA2330568A1 (fr)
DE (1) DE69906728T2 (fr)
DK (1) DK1082116T3 (fr)
ES (1) ES2197675T3 (fr)
NZ (1) NZ508422A (fr)
PT (1) PT1082116E (fr)
SE (1) SE9801516D0 (fr)
WO (1) WO1999056750A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6903187B1 (en) * 2000-07-21 2005-06-07 Allergan, Inc. Leucine-based motif and clostridial neurotoxins
DE10212564B4 (de) 2002-03-12 2007-04-19 Neurobiotec Gmbh 1-Allyl-ergotalkaloid-Derivate und ihre Verwendung zur Prophylaxe und Therapie von Migräne
NZ537629A (en) * 2002-07-19 2007-05-31 Biovitrum Ab Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2A receptor-related disorders
AU2004305563C1 (en) 2003-12-11 2011-07-07 Sunovion Pharmaceuticals Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
JP4646574B2 (ja) * 2004-08-30 2011-03-09 株式会社日立製作所 データ処理システム
EP1842556A4 (fr) * 2005-01-18 2008-12-17 Mitsubishi Tanabe Pharma Corp Agent therapeutique pour le traitement du trouble de l'hyperactivite avec deficit d'attention

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992546A (en) 1973-10-18 1976-11-16 Ciba-Geigy Corporation 4-Piperidinobutyrophenones as neuroleptics
CA1280421C (fr) 1985-07-02 1991-02-19 Albert A. Carr Derives piperidinyl disubstitutes en 1,4
ATE114467T1 (de) * 1990-06-01 1994-12-15 Merrell Dow Pharma (+)-alpha-(2,3 dimethoxyphenyl)-1-(2- (fluorophenyl)ethyl>-4-piperidinmethanol.
US5618824A (en) 1994-03-09 1997-04-08 Merrell Pharmaceuticals Inc. Treatment of obsessive-compulsive disorders with 5-HT2 antagonists

Also Published As

Publication number Publication date
ATE236634T1 (de) 2003-04-15
EP1082116B1 (fr) 2003-04-09
EP1082116A1 (fr) 2001-03-14
JP2002513759A (ja) 2002-05-14
WO1999056750A1 (fr) 1999-11-11
SE9801516D0 (sv) 1998-04-30
DE69906728T2 (de) 2004-02-26
CA2330568A1 (fr) 1999-11-11
DE69906728D1 (de) 2003-05-15
PT1082116E (pt) 2003-08-29
US6358977B1 (en) 2002-03-19
ES2197675T3 (es) 2004-01-01
AU4301699A (en) 1999-11-23
NZ508422A (en) 2002-05-31

Similar Documents

Publication Publication Date Title
SE0104334D0 (sv) Therapeutic agents
IS6459A (is) Arýl sambrædd azapólýsýklísk efnasambönd
MY117896A (en) Quinazoline derivatives
MY118163A (en) Aryl fused azapolycyclic compounds
MXPA01007940A (es) Derivados de azabicicloalcano y usos terapeuticos de los mismos.
DK1082116T3 (da) Anvendelse af 4-piperidinmethanolderivater til behandling af neurologiske sygdomme
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
ATE264104T1 (de) Immunmodulierende arzneimittelzusammenstellung
MXPA05006271A (es) Metodo para el tratamiento de desordenes del movimiento usando derivados de acido barbiturico.
DK36291D0 (da) Anvendelse af piperidylsubstituerede indolderivater til behandling af kognitive lidelser
ATE216233T1 (de) Indolditerpen alkaloide
HU912901D0 (en) Method for producing 3-(1h-indazole-3-yl)-4-pyridine amines and pharmaceutical preparatives containing said compounds
SE9900190D0 (sv) New compounds
DK0784973T3 (da) Quinoxalinderivater til behandling af tinnitus
NO20020475D0 (no) 2-aminotetralinderivater for terapi av glaukom
MX9703712A (es) Derivados de 6-metoxi-1h-benzotriazol-5-carboxamida, sus procesos de produccion y las composiciones farmaceuticas que los contienen.
AU5893398A (en) Pharmaceutical composition for the treatment of so-called restless legs